172 E. P. M. VIANNA ET AL.
2. Zimmermann H, Braun N. Ecto-nucleotidases: molecular structures,
catalytic properties, and functional roles in the nervous system. Prog
Brain Res 1999;120:371–85.
3. Schoen SW, Kreutzberg GW. Evidence that 5’-nucleotidase is as-
sociated with malleable synapses: an enzyme cytochemical investi-
gation of olfactory bulb of adult rats. Neuroscience 1995;65:37–50.
4. Dunwiddie TV, Masino SA. The role and regulation of adeno-
sine in the central nervous system. Annu Rev Neurosci 2001;24:31–
55.
5. Fastbom J, Pazos A, Palacios JM. The distribution of adenosine A1
receptors and 5´nucleotidase in the brain of some commonly used
experimental animals. Neuroscience 1987;22:813–26.
6. Thompson SM, Haas HL, Gahwiller BH. Comparison of the actions
of adenosine at pre and postsynapticreceptorsin the rat hippocampus
in vitro. J Physiol 1992;451:347–63.
7. Dunwiddie TV. The physiological role of adenosine in the central
nervous system. Int Rev Neurobiol 1985;27:63–139.
8. Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol
1999;79:1001–10.
9. Fredholm BB, Dunwiddie TV. How does adenosine inhibit trans-
mitter release? Trends Pharmacol 1988;9:130–4.
10. Jarvis MF, Williams M. Direct autoradiographic localization of
adenosine A2 receptors in the rat brain using A2-selective agonist,
[3H]CGS 21680. Eur J Pharmacol 1989;168:243–6.
11. Weiss SM, Benwell K, Cliffe IA, et al. Discovery of nonxanthine
adenosine A2a receptor antagonists for the treatment of Parkinson’s
disease. Neurology 2003;61:S101–6.
12. Cunha RA, Johansson B, Van Der Ploeg I, et al. Evidence for func-
tionally important adenosine A2a receptor in the rat hippocampus.
Brain Res 1994;649:208–16.
13. Lopes LV, Cunha RA, Ribeiro JA. Crosstalk between A1 and A2a
adenosine receptors in the hippocampus and cortex of young adult
and aged rats. J Neurophysiol 1999;82:3196–203.
14. Cunha RA, Ribeiro JA. Adenosine A2a receptor facilitation of
synaptic transmission in the CA1 area of the rat hippocampus re-
quires protein kinase C but not protein kinase A activation. Neurosci
Lett 2000;289:127–30.
15. Richardson PJ, Cunha RA. Extracellular metabolism and function of
purines in immunoisolated cholinergic nerve terminals. Neurochem
Int 1992;21(suppl):Q10.
16. Sebasti˜ao AM, Ribeiro JA. A2 receptor mediated excitatory actions
of adenosine in the nervous system. Prog Neurobiol 1996;48:167–
89.
17. von Lubitz DK, Lin RC, Popik P, et al. Adenosine A3 receptor
stimulation and cerebral ischemia. Eur J Pharmacol 1994;263:59–
67.
18. Dunwiddie TV, Diao L, Kim HO, et al. Activation of hippocampal
adenosine 3 receptors produces a heterologous desensitization of
A1 receptor mediated responses in rat hippocampus. J Neurosci
1997;17:607–14.
19. Etherington LAV, Frenguelli BG. Endogenous adenosine modu-
lates epileptiform activity in rat hippocampus in a receptor subtype-
dependent manner. Eur J Neurosci 2004;19:2539–50.
20. During MJ, Spencer DD. Adenosine: a potential mediator of seizure
arrest and postictal refractoriness. Ann. Neurol 1992;32:618–24.
21. George B, Kulkarni SK. Modulation of lithium-pilocarpine-induced
status epilepticus by adenosinergic agents. Methods Find Exp Clin
Pharmacol 1997;19:329–33.
22. Khan GM, Smolders I, Ebinger G, et al. Anticonvulsant ef-
fect and neurotransmitter modulation of focal and systemic 2-
chloroadenosine against the development of pilocarpine-induced
seizures. Neuropharmacology 2000;39:2418–32.
23. Gouder N, Fritschy JM, Boison D. Seizure suppression by adeno-
sine A1 receptor activation in a mouse model of pharmacoresistant
epilepsy. Epilepsia 2003;44:877–85.
24. Dragunow M. Adenosine and epileptic seizure. In: Phillis JW, ed.
Adenosine and adenine nucleotides as regulators of cellular func-
tion. Boca Raton: CRC Press; 1991:367–79.
25. Cavalheiro EA. Pilocarpine model of epilepsy. Ital J Neurol Sci
1995;16:33–7.
26. Mello LEAM, CavalheiroEA, Tan AM, et al. Granule cell dispersion
in relation to mossy fiber sprouting, hippocampal cell loss, silent
period and seizure frequency in the pilocarpine model of epilepsy.
In: Engel J Jr, Wasterlain C, Cavalheiro EA, et al, eds. Molecular
neurobiology of epilepsy. Amsterdam: Elsevier; 1992:51–61.
27. Turski WA, Cavalheiro EA, Schwarz M, et al. Limbic seizures pro-
duced by pilocarpine in rats: behavioural, electroencephalographic
and neuropathological study. Behav Brain Res 1983;9:315–35.
28. Leite JP, Bortolotto ZA, Cavalheiro EA. Spontaneous recurrent
seizures in rats: an experimental model of partial epilepsy. Neurosci
Biobehav Rev 1990;14:511–7.
29. Cavalheiro EA, Calderazzo-Filho LS, Bortolotto ZA, et al. Anticon-
vulsant role of adenosine. PolJPharmacol 1987;39:537–44.
30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Syd-
ney: Academic; 1986.
31. Abercrombie M. Estimation of nuclear population from microtome
sections. Anat Rec 1946;94:239–47.
32. Bailly YL, Schoen SW, Mariani J, et al. Immature chemodifferen-
tiation of Purkinje cell synapses revealed by 5`nucleotidase ecto-
enzyme activity in the cerebellum of the reeler mouse. Synapse
1998;29:279–92.
33. Rebola N, Coelho JE, Costenla AR, et al. Decrease of adenosine
A1 receptor density and of adenosine neuromodulation in the hip-
pocampus of kindled rats. Eur J Neurosci 2003;18:820–8.
34. Jones PA, Smith RA, Stone TW. Protection against kainite-induced
excitotoxicity by adenosine A2a receptor agonists and antagonists.
Neuroscience 1998;85:229–37.
35. MacGregor DG, Jones PA, Maxwell WL, et al. Prevention by a
purine analogue of kainite-induced neuropathology in rat hippocam-
pus. Brain Res 1996;725:115–20.
36. Brundege JM, Dunwiddie TV. Role of adenosine as a modulator
of synaptic activity in the central nervous system. Adv Pharmacol
1997;39:353–91.
37. Moreau JL, Huber G. Central adenosine A2a receptors: an overview.
Brain Res Rev 1999;31:65–82.
38. Mendon¸ca A, Sebasti˜ao AM, Ribeiro JA. Adenosine does it have a
neuroprotective role after all? Brain Res Rev 2000;33:258–74.
39. Chen JF, Huang Z, Ma J, et al. A2a adenosine receptor deficiency
attenuates brain injury induced by transient focal ischemia in mice.
J Neurosci 1999;19:9192–200.
40. Sebastiao AM, Ribeiro JA. Fine-tuning neuromodulation by adeno-
sine. Trends Pharmacol Sci 2000;21:341–6.
41. Monopoli A, Lozza G, Forlani A, et al. Blockade of adenosine A2a
receptors results in neuroprotective effects in cerebral ischemia in
rats. Neuroreport 1998;9:3955–9.
42. Schwarzchild MA, Xu K, Oztas E, et al. Neuroprotection by caffeine
and more specific A2a receptor antagonists in animal models of
Parkinson’s disease. Neurology 2003;61:S55–61.
43. Huber A, Guttinger M, Mohler H, et al. Seizure suppression by
adenosine A2a receptor activation ina rat model of audiogenic brain-
stem epilepsy. Neurosci Lett 2002;329:289–92.
44. Zhang JM, Wang HK, Ye CQ, et al. Activation of adenosine A1
receptors underlies anticonvulsant effect of CGS21680. Eur J Phar-
macol 1994;255:239–43.
45. Cunha RA, Ribeiro JA. Purinergic modulation of [
3
H]GABA re-
lease from rat hippocampal nerve terminals. Neuropharmacology
2000;39:1156–67.
46. Rebola N, Pinheiro PC, Oliveira CR, et al. Subcellular localization
of adenosine A1 receptors in nerve terminals and synapses of the rat
hippocampus. Brain Res 2003;987:49–58.
47. Popoli P, Pintor A, Domenici MR, et al. Blockade of adenosine A2a
receptors reduces, through a pre-synaptic mechanism, quinolinic
acid-induced excitotoxicity: possible relevance to neuroprotective
interventions in neurodegenerative diseases of the striatum. J Neu-
rosci 2002;22:1967–75.
48. Bona E, Ad´en U, Giland E, et al. Neonatal cerebral hypoxia-
ischemia: the effect of adenosine receptor antagonists. Neurophar-
macology 1997;36:1327–38.
49. Ongini E, Schubert P. Neuroprotection induced by stimulating A1
or blocking A2a adenosine receptors: an apparent paradox. Drug
Dev Res 1998;45:387–93.
50. Nehlig A, Daval JL, Boyet S. Effects of selective adenosine A1
and A2 receptor agonists and antagonists on local rates of energy
metabolism in the rat brain. Eur J Pharmacol 1994;258:57–66.
51. Fernandes MJS, Dub´eC,Boyet S, et al. Correlation between hyper
metabolism and neuronal damage during status epilepticus induced
Epilepsia, Vol. 46, Suppl. 5, 2005